NCT05627648 - Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

August 31, 2026

Conditions

Vocal Fold Scar

Interventions

DRUG

KP-100LI

Intracordal injection, 20 mcg once per week, 3 weeks

DRUG

Placebo

Intracordal injection, once per week, 3 weeks

Trial Locations (8)

RECRUITING

Fujita Health University Hospital, Toyoake

RECRUITING

Fukuoka Sanno Hospital, Fukuoka

RECRUITING

Kurume University Hospital, Kurume

RECRUITING

University Hospital Kyoto Prefectural University of Medicine, Kamigyō-ku

RECRUITING

Tohoku University Hospital, Sendai

RECRUITING

Kawasaki Medical School Hospital, Kurashiki

RECRUITING

Nihon University Hospital, Chiyoda-ku

RECRUITING

Sanno Medical Center, Minato-Ku